|« Previous month||Next month »|
29-Nov-2012 - The industry group that prompted the USP to delay new elemental impurities standards says even when completed, ICH Q3D will take time to implement.
29-Nov-2012 - Belgian biopharmaceutical company UCB has agreed to sell its manufacturing plant in Vapi, India to API maker Exemed Pharmaceuticals.
29-Nov-2012 - The group behind the excipient certification scheme Excipact will train SGS and blue inspection body GmbH auditors under agreements signed this week.
28-Nov-2012 - The US Federal Trade Commission (FTC) says making insignificant reformulations to drugs to block generic competition violates antitrust laws.
28-Nov-2012 - Hovione and Solvias have become the latest suppliers to team on drug solubility and bioavailability services in a new deal announced today.
28-Nov-2012 - in-PharmaTechnologist.com presents its latest round-up of movers and shakers in the world of pharmaceuticals, including news from Cipla, Dr. Reddy’s and Immunogen.
27-Nov-2012 - Pfizer is re-jigging its failed virtual trial model and could re-launch the programme as soon as 2013.
27-Nov-2012 - The bioavailability market lacks a leader that can offer comprehensive solutions according to Merck Millipore, which has set its sights on filling the gap through investments and a new lab....
27-Nov-2012 - "Church brand Chihpen Tianyun capsule”,“wind pain Kang membrane ball” and “brain Xuesaitong pill” are just three of the ‘drug’ products named and shamed by China’s SFDA in a clampdown on...
27-Nov-2012 - The USP has delayed new elemental impurities standards but is still confident they can be harmonized with ICH Q3D even if May 2014 implementation target is kept.
27-Nov-2012 - Rhenovia Pharma says the multi-drug delivery capabilities of its transdermal-patch could have wider application.
26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
26-Nov-2012 - APIs made in Switzerland won’t need ‘written confirmation’ of quality after the EC deemed the country's manufacturing standards meet its requirements.
26-Nov-2012 - Indian Plans to hand quality oversight of APIs shipped to Europe to ‘competent authority’ are still being discussed according to Pharmexcil.
26-Nov-2012 - Euticals Limited has halted API production at its Welsh site after local authorities found it was housing “substantial” quantities of a potentially explosive chemical.
22-Nov-2012 - in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics and Bend Research.
22-Nov-2012 - The European Commission (EC) has asked the industry how long it will take to change labels of drugs marked for additional post-market monitoring.
22-Nov-2012 - Johnson Matthey saw an uptick in its API business thanks to demand for “higher margin” products.
22-Nov-2012 - Brazilian drug regulator Anvisa wants to engage with the pharmaceutical industry on the disposal of unused drugs.
21-Nov-2012 - BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.
21-Nov-2012 - US insurers will cover more medicines under Obamacare according to a document published by the Department of Health and Human Services (DHSS) in the Federal Register earlier this week.
21-Nov-2012 - Fujifilm has developed a new “pain-free” alternative to hypodermic needles which delivers drugs through a sheet of material covered in tiny dissolvable needles.
21-Nov-2012 - Improper antibiotic use is driving the ‘Superbug’ epidemic but irresponsible promotional may be exacerbating the problem according to the WHO.
20-Nov-2012 - The US FDA has finally adopted the revised ICH Q11 guidelines on drug substance manufacturing nearly six months after European regulators embraced the guidelines.
|« Previous month||Next month »|